Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2372
    -0.0067 (-0.54%)
     
  • Bitcoin GBP

    51,832.12
    +540.35 (+1.05%)
     
  • CMC Crypto 200

    1,379.99
    +67.37 (+5.13%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.25
    +0.52 (+0.63%)
     
  • GOLD FUTURES

    2,402.60
    +4.60 (+0.19%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Insights on the Fetal Monitoring Global Market to 2026 - Featuring Dixion, GE Healthcare and Monarch Meditech Among Others

Dublin, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The "Fetal Monitoring Market Research Report by Portability, by Application, by End User, by Product, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Fetal Monitoring Market size was estimated at USD 3,498.55 Million in 2020 and expected to reach USD 3,777.80 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.32% to reach USD 5,651.27 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Fetal Monitoring to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Portability, the Fetal Monitoring Market was studied across Non-Portable Systems and Portable Systems.

  • Based on Method, the Fetal Monitoring Market was studied across Invasive Method and Noninvasive Method.

  • Based on Application, the Fetal Monitoring Market was studied across Antepartum and Intrapartum.

  • Based on End User, the Fetal Monitoring Market was studied across Home Care Settings, Hospitals, and Obstetrics & Gynecology Clinics.

  • Based on Product, the Fetal Monitoring Market was studied across Accessories And Consumables, Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, Fetal Electrodes, Telemetry Devices, Ultrasound Devices, and Uterine Contraction Monitors.

  • Based on Region, the Fetal Monitoring Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

ADVERTISEMENT

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Fetal Monitoring Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Fetal Monitoring Market, including Advanced Instrumentations (US), Bionet Co., Ltd. (South Korea), BISTOS (Korea), BRAEL-Medical Equipment (Poland), Cardinal Health, Inc. (US), ChoiceMMed (China), CONTEC Medical Systems Co., Ltd. (China), Dixion (Germany), Dott Medical Co. Ltd. (China), EDAN Diagnostics, Inc. (China), FUJIFILM SonoSite, Inc. (US), GE Healthcare (US), GPC Medical (India), Huntleigh Healthcare Limited (UK), Koninklijke Philips N.V. (Netherlands), Life Plus (India), MedGyn Products, Inc (US), Mediana (Korea), Monarch Meditech (India), Natus Medical Incorporated (US), Neoventa Medical AB (Sweden), Progetti Srl (Italy), Promed Group Co., Ltd. (Hong Kong), Shenzhen Comen Medical Instruments Co., Ltd. (China), ShenZhen Luckcome Technology Inc. (China), Siemens Healthineers (Germany), The Cooper Companies Inc. (US), TRISMED Co., Ltd. (Republic of Korea), and Trivitron Healthcare (India).

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Fetal Monitoring Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Fetal Monitoring Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Fetal Monitoring Market?
4. What is the competitive strategic window for opportunities in the Global Fetal Monitoring Market?
5. What are the technology trends and regulatory frameworks in the Global Fetal Monitoring Market?
6. What is the market share of the leading vendors in the Global Fetal Monitoring Market?
7. What modes and strategic moves are considered suitable for entering the Global Fetal Monitoring Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in birth rates & preterm births worldwide
5.1.1.2. Government initiatives and awareness for better fetal care
5.1.1.3. High adoption for fetal heart monitoring
5.1.2. Restraints
5.1.2.1. Accuracy concerns
5.1.2.2. Technological limitations and subjective interpretations
5.1.3. Opportunities
5.1.3.1. Wearable technology devices for fetal monitoring
5.1.3.2. Rising preferences for non-invasive fetal monitoring
5.1.4. Challenges
5.1.4.1. Often difficulties in finding and counting fetal heart rate
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Fetal Monitoring Market, by Portability
6.1. Introduction
6.2. Non-Portable Systems
6.3. Portable Systems

7. Fetal Monitoring Market, by Method
7.1. Introduction
7.2. Invasive Method
7.3. Noninvasive Method

8. Fetal Monitoring Market, by Application
8.1. Introduction
8.2. Antepartum
8.3. Intrapartum

9. Fetal Monitoring Market, by End User
9.1. Introduction
9.2. Home Care Settings
9.3. Hospitals
9.4. Obstetrics & Gynecology Clinics

10. Fetal Monitoring Market, by Product
10.1. Introduction
10.2. Accessories And Consumables
10.3. Electronic Maternal/Fetal Monitors
10.4. Fetal Doppler Devices
10.5. Fetal Electrodes
10.6. Telemetry Devices
10.7. Ultrasound Devices
10.8. Uterine Contraction Monitors

11. Americas Fetal Monitoring Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Fetal Monitoring Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Thailand

13. Europe, Middle East & Africa Fetal Monitoring Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Advanced Instrumentations (US)
15.2. Bionet Co., Ltd. (South Korea)
15.3. BISTOS (Korea)
15.4. BRAEL-Medical Equipment (Poland)
15.5. Cardinal Health, Inc. (US)
15.6. ChoiceMMed (China)
15.7. CONTEC Medical Systems Co., Ltd. (China)
15.8. Dixion (Germany)
15.9. Dott Medical Co. Ltd. (China)
15.10. EDAN Diagnostics, Inc. (China)
15.11. FUJIFILM SonoSite, Inc. (US)
15.12. GE Healthcare (US)
15.13. GPC Medical (India)
15.14. Huntleigh Healthcare Limited (UK)
15.15. Koninklijke Philips N.V. (Netherlands)
15.16. Life Plus (India)
15.17. MedGyn Products, Inc (US)
15.18. Mediana (Korea)
15.19. Monarch Meditech (India)
15.20. Natus Medical Incorporated (US)
15.21. Neoventa Medical AB (Sweden)
15.22. Progetti Srl (Italy)
15.23. Promed Group Co., Ltd. (Hong Kong)
15.24. Shenzhen Comen Medical Instruments Co., Ltd. (China)
15.25. ShenZhen Luckcome Technology Inc. (China)
15.26. Siemens Healthineers (Germany)
15.27. The Cooper Companies Inc. (US)
15.28. TRISMED Co., Ltd. (Republic of Korea)
15.29. Trivitron Healthcare (India)

16. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/fhqu4i

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900